Use of Donor-Derived-Cell-Free DNA as a Marker of Early Allograft Injury in Primary Graft Dysfunction (PGD) to Predict the Risk of Chronic Lung Allograft Dysfunction (CLAD)

Title
Use of Donor-Derived-Cell-Free DNA as a Marker of Early Allograft Injury in Primary Graft Dysfunction (PGD) to Predict the Risk of Chronic Lung Allograft Dysfunction (CLAD)
Authors
Keywords
Primary graft dysfunction (PGD), Chronic lung allograft dysfunction (CLAD), Donorderived cell-free DNA (ddcfDNA), Rejection
Journal
Publisher
Elsevier BV
Online
2021-02-21
DOI
10.1016/j.healun.2021.02.008

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now